General Information of the Compound
| Compound ID |
CP0433938
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-[2-[4-[(2-methylquinolin-5-yl)oxymethyl]piperidin-1-yl]acetyl]-4H-1,4-benzoxazin-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H27N3O4
|
||||||||||||||||||
| Molecular Weight |
445.519
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc2c(OCC3CCN(CC(=O)c4ccc5OCC(=O)Nc5c4)CC3)cccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H27N3O4/c1-17-5-7-20-21(27-17)3-2-4-24(20)32-15-18-9-11-29(12-10-18)14-23(30)19-6-8-25-22(13-19)28-26(31)16-33-25/h2-8,13,18H,9-12,14-16H2,1H3,(H,28,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GHGGALKHUTUYDT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01202, 5-hydroxytryptamine receptor 1B
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D